⌘K

Home/Filings/4/0001787306-24-000014

4//SEC Filing

Smither John W 4

Accession 0001787306-24-000014

CIK 0001787306other

View on SEC.gov Company Profile

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 6:23 PM ET

Size

12.1 KB

Accession

0001787306-24-000014

Insider Transaction Report

Form 4

Period: 2024-02-13

Arcutis Biotherapeutics, Inc.ARQT

Chief Financial Officer

Transactions

Award
Common Stock
2024-02-13+2,793→ 2,793 total
Award
Common Stock
2024-02-13+8,572→ 11,365 total
Disposition to Issuer
Stock Option (right to buy)
2024-02-13−8,379→ 0 total
Exercise: $27.61Exp: 2025-03-31→ Common Stock (8,379 underlying)
Disposition to Issuer
Stock Option (right to buy)
2024-02-13−25,718→ 0 total
Exercise: $32.44Exp: 2025-03-31→ Common Stock (25,718 underlying)

Holdings

Common Stock
(indirect: By Trust)
141,392

Footnotes (5)

[F1]On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on February 27, 2020, and received in exchange for the option, these Restricted Stock Units ("RSUs") that vest in four equal quarterly installments commencing May 1, 2024.
[F2]On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2021, and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024.
[F3]The securities are held of record by The 1994 Smither Family Trust, as Amended and Restated in 2014, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
[F4]This option is fully vested.
[F5]This option is fully vested.

Documents

1 file

4
wk-form4_1708039415.xmlPrimary
FORM 4

Issuer

Arcutis Biotherapeutics, Inc.

CIK 0001787306

Entity typeother

Related Parties

1

filerCIK 0001559583

Filing Metadata

Form type: 4
Filed: Feb 14, 7:00 PM ET
Accepted: Feb 15, 6:23 PM ET
Size: 12.1 KB

View on SEC.gov